Author: Chad Eichman, PhD – BioPharmaceutical Global Marketing Manager What are protein therapeutics / monoclonal antibodies? Protein therapeutics, specifically monoclonal antibodies (mAbs), have emerged as the most marketed biologic drug Continue Reading
Author: Chad Eichman, PhD – BioPharmaceutical Global Marketing Manager How Biosimilars are Affecting the Pharmaceutical Industry Honey Nut Cheerios™ or Honey Nut Tasteeos®? Glad® Trash Bags or Walmart’s Great Value™ Continue Reading
Scientists are some of the smartest people to walk the planet. But even basic chromatography knowledge can evade the most experienced scientist. That is why Phenomenex provides technical assistance nearly Continue Reading
When working in biopharmaceutical or biologics analysis, you need as many tools as possible. Be it that you’re looking for the right instruments (like our new bioZen™ LC columns), the Continue Reading
Meet James Song, R&D Research Scientist– Bioseparations James has over 20 years of experience in the arena of biotechnology and has a wealth of experience in the fields of diagnostic Continue Reading
Biopharmaceuticals have emerged as the next-gen of therapeutic (large and small) molecules in the pharmaceutical industry Guest Author: Chad Eichman, Ph.D., Biopharmaceutical Industry Manager The pharmaceutical industry has a long-standing Continue Reading
By Guest Author: Brian Rivera Contrary to popular belief, size exclusion chromatography (SEC) isn’t straightforward. However, it should be—it’s a non-absorptive separation, right? Just look up an SEC column’s calibration Continue Reading
A social media sensation has finally paid off. The U.S. Food and Drug Administration (FDA) has recently approved the first drug to combat amyotrophic lateral sclerosis, or ALS, in 22 years. Continue Reading
